Fingerprint
Dive into the research topics of 'Bortezomib-based Chemotherapy for Multiple Myeloma Patients Without Comorbid Cardiovascular Disease Shows No Cardiotoxicity'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Bortezomib-based Chemotherapy for Multiple Myeloma Patients Without Comorbid Cardiovascular Disease Shows No Cardiotoxicity
Stephen B. Heitner, Jessica Minnier, Aynun Naher, Ryan C. Van Woerkom, Alexandra Ritts, Maros Ferencik, Craig Broberg, Eva Medvedova, Rebecca Silbermann, Emma C. Scott
Research output: Contribution to journal › Article › peer-review
1
Scopus
citations